{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:05Z","timestamp":1792425605991,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Atopic dermatitis (AD) is a common chronic, recurrent inflammatory disease, yet its accompanying nail abnormalities have long received insufficient attention. The clinical characteristics, underlying mechanisms, and assessment systems for nail dystrophy in AD remain unclear. AD-associated nail dystrophy can manifest in various forms, including Beau\u2019s lines, nail pitting, koilongchia, trachyonychia, leukonychia, brachyonychia, melanoychia, onychomadesis, onychoschizia, onycholysis, and paronychia. Current treatments face limitations such as slow onset of action and uncertain efficacy with traditional therapies, particularly with limited drug options for the pediatric populations. With the deepening of research into the Th2 inflammatory pathway, biologics such as dupilumab have shown therapeutic potential. Through retrospective analysis, this paper presents the effectiveness and safety of dupilumab in five pediatric AD patients with nail dystrophy under 12 years old. After at least 12 weeks of treatment, their skin lesions and nail dystrophy both showed marked improvement. Additionally, we reviewed four reported cases in the literature of adult AD patients with nail dystrophy who experienced significant improvement in nail changes after dupilumab treatment. These results suggest that dupilumab may be an effective treatment for nail dystrophy in AD. This case series provides the first evidence demonstrating the significant efficacy of dupilumab for nail dystrophy in pediatric AD patients. However, further large-scale prospective studies are still needed to better guide clinical practice.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1668182","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T06:34:17Z","timestamp":1771310057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Nail dystrophy successfully treated with dupilumab in pediatric atopic dermatitis: case series and literature review"],"prefix":"10.3389","volume":"17","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Dermatology and Venereology, Sichuan Provincial People\u2019s Hospital University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Dermatology and Venereology, Sichuan Provincial People\u2019s Hospital University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Dermatology and Venereology, Sichuan Provincial People\u2019s Hospital University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Dermatology and Venereology, Sichuan Provincial People\u2019s Hospital University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Dermatology and Venereology, Sichuan Provincial People\u2019s Hospital University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14726","article-title":"Nail manifestations in atopic dermatitis: a systematic review","volume":"59","author":"Chng","year":"2020","journal-title":"Int J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_445_24","article-title":"Biologics and small molecules for inflammatory nail disorders: A narrative review","volume":"16","author":"Forman","year":"2024","journal-title":"Indian Dermatol Online J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2023.0394","article-title":"Treatment of refractory hand and foot eczema with nail involvement using upadacitinib: A case report","volume":"36","author":"Yu","year":"2025","journal-title":"Dermatitis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17673","article-title":"Effectiveness of upadacitinib in the treatment of chronic hand eczema and nail-associated changes in a patient with atopic dermatitis","volume":"64","author":"Bonzano","year":"2025","journal-title":"Int J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14169","article-title":"Median canaliform nail dystrophy of Heller in a patient with atopic dermatitis: \u2018miraculous\u2019 healing with dupilumab","volume":"45","author":"Giura","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13633","article-title":"Nail changes successfully treated with dupilumab in a patient with severe atopic dermatitis","volume":"62","author":"Navarro-Trivi\u00f1o","year":"2021","journal-title":"Australas J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.10.024","article-title":"Onychodystrophy associated with dupilumab therapy for atopic dermatitis","volume":"7","author":"Zubek","year":"2020","journal-title":"JAAD Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S524384","article-title":"Dupilumab for atopic dermatitis with twenty-nail dystrophy: A case report","volume":"18","author":"Li","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2025.03.040","article-title":"Dupilumab for the treatment of atopic dermatitis and alopecia areata with incidental improvement of trachyonychia","volume":"63","author":"Chung","year":"2025","journal-title":"JAAD Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16892","article-title":"ETFAD\/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children","volume":"34","author":"Wollenberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00958.x","article-title":"Minor cutaneous features of atopic dermatitis in South Korea","volume":"39","author":"Lee","year":"2000","journal-title":"Int J Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2006.06005","article-title":"Prevalence and morphology of hand eczema in patients with atopic dermatitis","volume":"17","author":"Simpson","year":"2006","journal-title":"Dermatitis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12088","article-title":"Clinical study of patients with hand eczema accompanied by nail dystrophy","volume":"40","author":"Yu","year":"2013","journal-title":"J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2019.31.2.121","article-title":"Nail dystrophy in patients with atopic dermatitis and its association with disease severity","volume":"31","author":"Chung","year":"2019","journal-title":"Ann Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5021\/ad.2014.26.1.26","article-title":"Epidemiology and clinical features of atopic dermatitis in kerman, a desert area of Iran","volume":"26","author":"Farajzadeh","year":"2014","journal-title":"Ann Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.12788\/cutis.1041","article-title":"Tackling inflammatory and infectious nail disorders in children","volume":"114","author":"Axler","year":"2024","journal-title":"Cutis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1440-0960.2002.00567.x","article-title":"Diseases of the generative nail apparatus. Part I: Nail matrix","volume":"43","author":"Nicolopoulos","year":"2002","journal-title":"Australas J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2002.00588.x","article-title":"Diseases of the generative nail apparatus. Part II: nail bed","volume":"43","author":"Goodman","year":"2002","journal-title":"Australas J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14783","article-title":"Assessment of nail findings in children with atopic dermatitis","volume":"46","author":"Arslan Uku","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13084","article-title":"Coexisting median canaliform nail dystrophy and habit-tic deformity in a patient with atopic dermatitis","volume":"61","author":"Wang","year":"2020","journal-title":"Australas J Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e13427","DOI":"10.1111\/dth.13427","article-title":"Intralesional triamcinolone injections for the treatment of nail dystrophy: A case series","volume":"33","author":"Yoo","year":"2020","journal-title":"Dermatol Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00769.x","article-title":"Treatment of median canaliform nail dystrophy with topical 0.1% tacrolimus ointment","volume":"37","author":"Kim","year":"2010","journal-title":"J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb02540.x","article-title":"Onycholysis in a case of atopic eczema treated with PUVA photochemotherapy","volume":"17","author":"Morgan","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.25259\/IJDVL_238_2022","article-title":"Successful treatment of paediatric nail dystrophy using fractional CO2 laser combined with topical corticosteroids","volume":"89","author":"Lee","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19065","article-title":"Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis","volume":"182","author":"Wollenberg","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1668182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T06:34:18Z","timestamp":1771310058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1668182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2026.1668182"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1668182","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"article-number":"1668182"}}